Proteintech CoraLite fluorescent-dye conjugated antibodies

Tuesday, 01 December, 2020 | Supplied by: Millennium Science Pty Ltd

Proteintech CoraLite fluorescent-dye conjugated antibodies

Proteintech’s monoclonal and polyclonal antibodies are now available directly conjugated with fluorescent dyes: CoraLite488, CoraLite594 and CoraLite647. They act as useful tools for immunofluorescence studies requiring multiplex co-labelling studies without the need for secondary antibodies.

The antibodies can be used directly in immunofluorescence studies without the need for secondary antibodies. Offering bright and long-lasting fluorescence, they can be multiplexed with other CoraLite dyes and dyes (eg, nuclear stains, DAPI, etc).

CoraLite fluorescent-dye conjugated antibodies are precise tools for a broad range of fluorescent-based research applications such as immunofluorescence, flow cytometry and ELISA-like assays.

The CoraLite dyes have equivalent brightness to the Alexa Fluor line. Additionally, each fluorophore can be used simultaneously in co-localisation studies due to the minimum overlapping fluorescence spectra. The CoraLite line of fluorescent conjugated antibodies are designed to enable faster and simultaneous detection of multiple targets in one experiment.

CoraLite488 is a bright green-fluorescent dye that is suitable for excitation by a 488 nm laser, while CoraLite594 and CoraLite647 are red-fluorescent dyes with maximum absorptions at wavelengths of 594 and 647 nm, respectively.

For more information: https://www.ptglab.com/products/coralite-fluorescent-dye-conjugated-antibodies/.

Online: www.mscience.com.au
Phone: 1800 678 242
Related Products

Lumiprobe DusQ fluorescence quenchers

Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...

Enzo Life Sciences SCREEN-WELL Epigenetics library

Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...

LSBio PathPlus Cancer Antibodies

The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd